Trials / Completed
CompletedNCT01025934
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Campania Luigi Vanvitelli · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | |
| OTHER | sham |
Timeline
- First posted
- 2009-12-04
- Last updated
- 2009-12-04
Source: ClinicalTrials.gov record NCT01025934. Inclusion in this directory is not an endorsement.